Connect your AI

Revvity RVTY Compensation and benefits

Compensation and benefits at other companies

Charles River LaboratoriesCRL

$22.38M+70.4%

Veeva SystemsVEEV

$119.26M+6.3%

Bio-Rad LaboratoriesBIO

——

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Revvity's compensation and benefits?: Revvity (RVTY) reported compensation and benefits of $8.72M in Q1 2026.
How has Revvity's compensation and benefits changed year-over-year?: Revvity's compensation and benefits increased by 12.7% year-over-year, from $7.73M to $8.72M.